Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03787472 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Manufacturing Processes for a Reusable Multifocal Optical Design in a Presbyopic Population
A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 5
- Study locations
NCT03787472: Completed NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.
NCT03787472 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 45 participants, below the 138-participant average among 20 other Visual Acuity trials with a reported enrollment target (67% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03787472, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 5
- Study locations
Study Summary
The clinical study is a randomized-controlled, double-masked, crossover clinical trial with two study treatments to compare two study lens types and the initial performance, in terms of the subjective response after a period of lens dispensing. The study will last approximately 2 to 4 months.
Primary Outcome
Overall vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/pos
Conditions Studied
Interventions
- DEVICE JJV Investigational senofilcon A Multifocal Lens1
- DEVICE JJV Investigational senofilcon A Multifocal Lens2
Study Locations (5)
Ohio
- Western Reserve Vision Care, Inc - Beachwood
- ProCare Vision Centers - Granville
Florida
- Maitland Vision Center - Maitland
Missouri
- Advanced Eyecare - Raytown
New York
- Spectrum Eyecare - Jamestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-01-11 |
| Est. Completion | 2019-03-22 |
| Phase | NA |
What the finished NCT03787472 record still lists
NCT03787472 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 138-participant average among 20 other Visual Acuity trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which JJV Investigational senofilcon A Multifocal Lens1 is the first listed.
NCT03787472 lists 5 locations in 4 states (Ohio, Florida, Missouri).
Frequently Asked Questions
What is clinical trial NCT03787472 about?
NCT03787472 is a clinical study titled "Clinical Evaluation of Manufacturing Processes for a Reusable Multifocal Optical Design in a Presbyopic Population". The clinical study is a randomized-controlled, double-masked, crossover clinical trial with two study treatments to compare two study lens types and the initial performance, in terms of the subjective response after a period of lens dispensing. The study will last approximately 2 to 4 months.
What is the current status of trial NCT03787472?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2019-01-11. Estimated completion is 2019-03-22.
What conditions does trial NCT03787472 study?
This clinical trial studies the following conditions: Visual Acuity.
What interventions are being tested in trial NCT03787472?
The interventions under investigation include: JJV Investigational senofilcon A Multifocal Lens1 (DEVICE), JJV Investigational senofilcon A Multifocal Lens2 (DEVICE).
Who is sponsoring clinical trial NCT03787472?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03787472 being conducted?
This trial has 5 study locations across Florida, Missouri, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Visual Acuity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03787472's enrollment target sits among peer trials
45 17th of 20 higher than 4 of 20 other Visual Acuity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Visual Acuity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Effect of Scatter on Visual Performance
RECRUITING · NA
-
Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2
COMPLETED · NA
-
Evaluation of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses
COMPLETED · NA
-
Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
COMPLETED · NA
-
Clinical Evaluation of Approved Contact Lenses
COMPLETED · NA
-
Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI